STATERA BIOPHARMA, INC.
STATERA BIOPHARMA, INC. is a registered legal entity registered in United States under 3666863, and its current status with Delaware Division of Corporations is active. The company was incorporated on 6 May 2003 and lists its registered address as United States. 2 shareholders are on record for STATERA BIOPHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of STATERA BIOPHARMA, INC.
Two shareholders are currently on record for STATERA BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Extended Market Index Fund, holding 99.7% — a majority holding — followed by Tucker Asset Management LLC at 0.3%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Officers
4
Directors and officers of STATERA BIOPHARMA, INC.
Four officers are currently on record for STATERA BIOPHARMA, INC., filed with Delaware Division of Corporations. Blake Hawley D.v.m., M.b.a. serves as Executive Chairman; MICHAEL KEVIN HANDLEY serves as Ceo, President & Chairman Of The Board; Christopher Zosh serves as Executive Vp Of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer; Robert W. Buckheit Jr., Ph.d. serves as Chief Technology Officer. Management authority at STATERA BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of STATERA BIOPHARMA, INC.
STATERA BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Cytocom Subsidiary Inc. (United States)
- High Street Acquisition Corporation (United States)
Data availability
Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns STATERA BIOPHARMA, INC.?
Two shareholders are currently on record for STATERA BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Extended Market Index Fund, holding 99.7% — a majority holding — followed by Tucker Asset Management LLC at 0.3%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is STATERA BIOPHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for STATERA BIOPHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does STATERA BIOPHARMA, INC. have on record?
2 shareholders are shown on record for STATERA BIOPHARMA, INC..
What is STATERA BIOPHARMA, INC.'s company registration number?
STATERA BIOPHARMA, INC.'s registration number is 3666863, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is STATERA BIOPHARMA, INC. still an active company?
STATERA BIOPHARMA, INC.'s status on Delaware Division of Corporations is listed as active.
When was STATERA BIOPHARMA, INC. incorporated?
STATERA BIOPHARMA, INC. was incorporated on 6 May 2003, according to Delaware Division of Corporations.
What is STATERA BIOPHARMA, INC.'s registered address?
The registered address on file for STATERA BIOPHARMA, INC. is United States.
Who are the officers/directors of STATERA BIOPHARMA, INC.?
Four officers are currently on record for STATERA BIOPHARMA, INC., filed with Delaware Division of Corporations. Blake Hawley D.v.m., M.b.a. serves as Executive Chairman; MICHAEL KEVIN HANDLEY serves as Ceo, President & Chairman Of The Board; Christopher Zosh serves as Executive Vp Of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer; Robert W. Buckheit Jr., Ph.d. serves as Chief Technology Officer. Management authority at STATERA BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does STATERA BIOPHARMA, INC. have a parent company or subsidiaries?
STATERA BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to STATERA BIOPHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to STATERA BIOPHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access STATERA BIOPHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like STATERA BIOPHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 22 September 2026.